Pathological definitions of invasion, metastatic potential and responsiveness to targeted therapies

Lefkowitz, 1994, Intraductal (intracystic) papillary carcinoma of the breast and its variants: a clinicopathological study of 77 cases, Hum Pathol, 25, 802, 10.1016/0046-8177(94)90250-X Leal, 1998, Intracystic (encysted) papillary carcinoma of the breast: a clinical, pathological, and immunohistochemical study, Hum Pathol, 29, 1097, 10.1016/S0046-8177(98)90420-8 Maluf, 1995, Solid papillary carcinoma of the breast: a form of intraductal carcinoma with endocrine differentiation frequently associated with mucinous carcinoma, Am J Surg Pathol, 19, 1237, 10.1097/00000478-199511000-00003 Nassar, 2006, Clinicopathologic analysis of solid papillary carcinoma of the breast and associated invasive carcinomas, Am J Surg Pathol, 30, 501, 10.1097/00000478-200604000-00011 Collins, 2006, Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers, Am J Surg Pathol, 30, 1002, 10.1097/00000478-200608000-00011 Carter, 1983, Intracystic papillary carcinoma of the breast: after mastectomy, radiotherapy or excisional biopsy alone, Cancer, 1, 14 Solorzano, 2002, Treatment and outcome of patients with intracystic papillary carcinoma of the breast, Am J Surg, 184, 364, 10.1016/S0002-9610(02)00941-8 van’t Veer, 2002, Gene expression profiling predicts clinical outcome of breast cancer, Nature, 415, 530, 10.1038/415530a van de Vijver, 2002, A gene expression signature as a predictor of survival in breast cancer, N Engl J Med, 347, 1999, 10.1056/NEJMoa021967 Wang, 2005, Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer, Lancet, 365, 671, 10.1016/S0140-6736(05)17947-1 Sotiriou, 2006, Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis, J Natl Cancer Inst, 98, 262, 10.1093/jnci/djj052 Buyse, 2006, Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer, J Natl Cancer Inst, 98, 1183, 10.1093/jnci/djj329 Regan, 2006, Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays, J Natl Cancer Inst, 98, 1571, 10.1093/jnci/djj415 Viale, 2003, Histopathology of primary breast cancer, Breast, 12, 391, 10.1016/S0960-9776(03)00142-5 Perez, 2006, HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 Intergroup adjuvant trial, J Clin Oncol, 24, 3032, 10.1200/JCO.2005.03.4744 American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer, J Clin Oncol, 2007;25:118-45.